The risk and efficacy of anticoagulant therapy in the treatment of thromboembolic complications in patients with primary malignant brain tumors.
about
Ixolaris, a tissue factor inhibitor, blocks primary tumor growth and angiogenesis in a glioblastoma model.Perioperative management of neurosurgical patients receiving chronic anticoagulation therapy.Two Cases of Hemorrhage in Benign Brain Tumors during Systemic Heparinization. Case Reports.Therapeutic Anticoagulation in Patients with Primary Brain Tumors or Secondary Brain Metastasis.
P2860
The risk and efficacy of anticoagulant therapy in the treatment of thromboembolic complications in patients with primary malignant brain tumors.
description
1990 nî lūn-bûn
@nan
1990 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1990 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
name
The risk and efficacy of antic ...... rimary malignant brain tumors.
@ast
The risk and efficacy of antic ...... rimary malignant brain tumors.
@en
type
label
The risk and efficacy of antic ...... rimary malignant brain tumors.
@ast
The risk and efficacy of antic ...... rimary malignant brain tumors.
@en
prefLabel
The risk and efficacy of antic ...... rimary malignant brain tumors.
@ast
The risk and efficacy of antic ...... rimary malignant brain tumors.
@en
P2093
P1433
P1476
The risk and efficacy of antic ...... rimary malignant brain tumors.
@en
P2093
Altschuler E
Vertosick FT Jr
P304
74-6; discussion 77
P356
10.1097/00006123-199007000-00010
P407
P577
1990-07-01T00:00:00Z